Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Lucid Group has four programmes shortlisted for PMEA 2019

Lucid is celebrating four of their programmes being shortlisted in four categories at this year's PMEAs

Lucid Group Communications Limited

- PMLiVE

Mastering data protection in the pharma industry

‘Trip wires’ that pharma should look out for

- PMLiVE

Sobi set to spend up to $915m to acquire Dova Pharmaceuticals

Hopes to boost haematology franchise with lead drug Doptelet

- PMLiVE

Lynparza scores another positive phase 3 prostate cancer study

In specific mutations, risk of death was reduced by 66%

- PMLiVE

Avanir’s week goes from bad to worse with Alzheimer’s stumble

Suffers a blow as second phase 3 trial misses the mark

- PMLiVE

J&J’s Invokana gets lifeline with new kidney disease approval

Sales have been down since drug was linked to amputation risk

- PMLiVE

Transformation in healthcare professionals’ digital behaviours

How HCPs use digital technology – and how to understand their behaviours

- PMLiVE

WebMD set to acquire Aptus Health

Transaction includes Aptus' Univadis, EngagedMedia and Tomorrow Networks

- PMLiVE

Four Health in the Top 10!!

Creative Healthcare Agencies

Four Agency Worldwide

- PMLiVE

Johnson pledges £200m cash injection into UK’s life sciences sector

UK-based entrepreneurs “share his ambition”, says industry leader

- PMLiVE

GSK’s Zejula challenges AZ/Merck’s Lynparza in PARP inhibitor category

New data in ovarian cancer creates potential for market battle

- PMLiVE

Hancock says UK will consider mandatory vaccinations

Conservatives' also announce £13bn investment for hospitals over next decade

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links